HiramatsuK, NiedermanMS. Health-care-associated pneumonia: a new therapeutic paradigm. Chest, 2005; 128(6):3784–3787.
2.
KollefMH, ShorrA, TabakYP, GuptaV, LiuLZ, JohannesRS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest, 2005; 128(6):3854–3862. Erratum in: Chest 2006;129(3):831.
3.
American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med, 2005; 71(4):388–416.
4.
ShanJ, ChenHL, ZhuJH. Diagnostic accuracy of clinical pulmonary infection score for ventilator-associated pneumonia: a meta-analysis. Respir Care, 2011; 56(8):1087–1094.
5.
MorrowLE. Prevention strategies for healthcare-associated pneumonia. Semin Respir Crit Care Med, 2009; 30(1):86–91.
6.
FàbregasN, EwigS, TorresA, El-EbiaryM, RamirezJ, de la BellacasaJP, et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax, 1999; 54(10):867–873.
7.
Rea-NetoA, YoussefNC, TucheF, BrunkhorstF, RanieriVM, ReinhartK, SakrY. Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Critical Care, 2008; 12(2):R56.
8.
VincentJL, de Souza BarrosD, CianferoniS. Diagnosis, management, and prevention of ventilator-associated pneumonia. Drugs, 2010; 70(15):1927–1944.
9.
WunderinkRG, WoldenbergLS, ZeissJ, DayCM, CleminsJ, LacherDA. The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia. Chest, 1992; 101(2):458–463.
10.
PingletonSK, FagonJY, LeeperKVJr. Patient selection for clinical investigation of ventilator-associated pneumonia. Criteria for evaluating diagnostic techniques. Chest, 1992; 102(5 Suppl 1):553S–556S.
11.
Centers for Disease Control and Prevention. Healthcare-associated infections (HAIs). http://www.cdc.gov/hai. Accessed June 13, 2011.
12.
MillerPR, JohnsonJC3rd, KarchmerT, HothJJ, MeredithJW, ChangMC. National nosocomial infection surveillance system: from benchmark to bedside in trauma patients. J Trauma, 2006; 60(1):98–103.
13.
SkrupkyL, McConnellK, DallasJ, McMullenK, BoyleW, KollefM. A comparison of VAP rates as identified according to National Healthcare Safety Network (NSHN) and American College of Chest Physicians (ACCP) criteria in a medical/surgical ICU population (abstract). Crit Care Med, 2010; 38(12 Suppl):A403.
14.
PuginJ, AuckenthalerR, MiliN, JanssensJP, LewPD, SuterPM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic ‘blind' bronchoalveolar lavage fluid. Am Rev Respir Dis, 1991; 143(5 Pt 1):1121–1129.
15.
PapazianL, ThomasP, GarbeL, GuignonI, ThirionX, CharrelJ, et al. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med, 1995; 152(6 Pt 1):1982–1991.
16.
CroceMA, SwansonJM, MagnottiLJ, ClaridgeJA, WeinbergJA, WoodGC, et al. The futility of the clinical pulmonary infection score in trauma patients. J Trauma, 2006; 60(3):523–527. discussion 527–528.
17.
LuytCE, ChastreJ, FagonJY. Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia. Intensive Care Med, 2004; 30(5):844–852.
18.
SchurinkCA, Van NieuwenhovenCA, JacobsJA, Rozenberg-ArskaM, JooreHC, BuskensE, et al. Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer variability. Intensive Care Med, 2004; 3(2)0:217–224.
19.
FartoukhM, MaitreB, HonoréS, CerfC, ZaharJR, Brun-BuissonC. Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited. Am J Respir Crit Care Med, 2003; 168(2):173–179.
20.
FlanaganPG, FindlayGP, MageeJT, IonescuA, BarnesRA, SmithiesM. The diagnosis of ventilator-associated pneumonia using non-bronchoscopic, non-directed lung lavages. Intensive Care Med, 2000; 26(1):20–30.
21.
TorresA, FábregasN, EwigS, de la BellacasaJP, BauerTT, RamirezJ. Sampling methods for ventilator-associated pneumonia: validation using different histologic and microbiological references. Crit Care Med, 2000; 28(8):2799–2804.
22.
BalthazarAB, Von NowakonskiA, De CapitaniEM, BottiniPV, TerziRG, AraújoS. Diagnostic investigation of ventilator-associated pneumonia using bronchoalveolar lavage: comparative study with a postmortem lung biopsy. Braz J Med Biol Res, 2001; 34(8):993–1001.
23.
TorresA, el-EbiaryM, PadróL, GonzálezJ, de la Bellacasa, RamirezJ, et al. Validation of different techniques for the diagnosis of ventilator-associated pneumonia. Comparison with immediate postmortem pulmonary biopsy. Am J Respir Crit Care Med, 1994; 149(2 Pt 1):324–331.
24.
TorresA, El-EbiaryM, FábregasN, GonzálezJ, de la BellacasaJP, HernándezC, et al. Value of intracellular bacteria detection in the diagnosis of ventilator associated pneumonia. Thorax, 1996; 51(4):378–384.
25.
KirtlandSH, CorleyDE, WinterbauerRH, SpringmeyerSC, CaseyKR, HampsonNB, DreisDF. The diagnosis of ventilator-associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria. Chest, 1997; 112(2):445–457.
26.
MarquetteCH, CopinMC, WalletF, NeviereR, SaulnierF, MathieuD, et al. Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med, 1995; 151(6):1878–1888.
27.
PapazianL, Autillo-TouatiA, ThomasP, BregeonF, GarbeL, SauxP, et al. Diagnosis of ventilator-associated pneumonia: an evaluation of direct examination and presence of intracellular organisms. Anesthesiology, 1997; 87(2):268–276.
28.
RoubyJJ, RossignonMD, NicolasMH, Martin de LassaleE, CristinS, GrossetJ, ViarsP. A prospective study of protected bronchoalveolar lavage in the diagnosis of nosocomial pneumonia. Anesthesiology, 1989; 71(5):679–685.
29.
RiazOJ, MalhotraAK, AboutanosMB, DuaneTM, GoldbergAE, BorchersCT, et al. Bronchoalveolar lavage in the diagnosis of ventilator-associated pneumonia: to quantitate or not, that is the question. Am Surg, 2011; 77(3):297–303.
30.
Christ-CrainM, MüllerB. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J, 2007; 30(3):556–573.
31.
Christ-CrainM, MüllerB. Procalcitonin and pneumonia: is it a useful marker?. Curr Infect Dis Rep, 2007; 9(3):233–240.
32.
IpM, RainerTH, LeeN, ChanC, ChauSS, LeungW, et al. Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections. Diagn Microbiol Infect Dis, 2007; 59(2):131–136.
33.
Christ-CrainM, Jaccard-StolzD, BingisserR, GencayMM, HuberPR, Tamm M MüllerB. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet, 2004; 363(9409):600–607.
34.
Christ-CrainM, StolzD, BingisserR, MüllerC, MiedingerD, HuberPR, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med, 2006; 174(1):84–93.
35.
BrielM, SchuetzP, MuellerB, YoungJ, SchildU, NusbaumerC, et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med, 2008; 168(18):2000–2007. discussion 2007–2008.
36.
RamirezP, GarciaMA, FerrerM, AznarJ, ValenciaM, SahuquilloJM, et al. Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J, 2008; 31(2):356–362.
37.
LuytCE, CombesA, ReynaudC, HekimianG, NieszkowskaA, TonnellierM, et al. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med, 2008; 34(8):1434–1440.
38.
DallasJ, BrownSM, HockK, ScottMG, SkrupkyLP, BoyleWA3rd, KollefMH. Diagnostic utility of plasma procalcitonin for nosocomial pneumonia in the ICU setting. Respir Care, 2011; 56(4):412–419.
39.
Christ-CrainM, MüllerB. Calcitonin peptides-the mediators in sepsis or just another fairy tale?. Crit Care Med, 2008; 36(5):1684–1687.
40.
BouadmaL, LuytCE, TubachF, CraccoC, AlvarezA, SchwebelC, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet, 2010; 375(9713):463–474.
41.
KollefMH. Will procalcitonin reduce antibiotic use in intensive care?. Lancet, 2010; 375(9713):435–436.
42.
IreguiM, WardS, ShermanG, FraserVJ, KollefMH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest, 2002; 122(1):262–268.
43.
KollefMH, KollefKE. Antibiotic utilization and outcomes for patients with clinically suspected ventilator-associated pneumonia and negative quantitative BAL culture results. Chest, 2005; 128(4):2706–2713.
44.
FagonJY, ChastreJ, WolffM, GervaisC, Parer-AubasS, StéphanF, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med, 2000; 132(8):621–630.
45.
HeylandDK, CookDJ, MarshallJ, HeuleM, GuslitsB, LangJ, JaeschkeR. The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia. Canadian Critical Care Trials Group Chest, 1999; 115(4):1076–1084.
46.
ShorrAF, ShernerJH, JacksonWL, KollefMH. Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis. Crit Care Med, 2005; 33(1):46–53.
47.
Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med, 2006; 355(25):2619–2630.
48.
KollefMH. Diagnosis of ventilator-associated pneumonia. N Engl J Med, 2006; 355(25):2691–2693. Erratum in: N Engl J Med 2007;356(12):1283.
49.
IbrahimEH, WardS, ShermanG, SchaiffR, FraserVJ, KollefMH. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med, 2001; 29(6):1109–1115.
50.
MicekST, WardS, FraserVJ, KollefMH. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest, 2004; 125(5):1791–1799.
